TIG Advisors LLC’s Edwards Lifesciences EW Stock Holding History

TIG Advisors LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-175,000	Closed	-$13M	–	67
2024 Q4	$13M	Buy	+175,000	New	+$12.2M	0.91%	26

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

TIG Advisors LLC's EW Position: Q1 2025 in Review

TIG Advisors LLC sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 14,215 shares — an estimated $1.05M sold.

TIG Advisors LLC first reported a position in EW in Q4 2024 and held it in 1 quarter. The position peaked at $1.05M in Q4 2024. 1,204 funds tracked by Wall St. Rank hold EW as of Q1 2025.

TIG Advisors LLC reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
TIG Advisors LLC sold 14,215 Edwards Lifesciences shares in Q1 2025, an estimated $1.05M.
TIG Advisors LLC first reported a position in Edwards Lifesciences in Q4 2024 and held it in 1 quarter.
TIG Advisors LLC's Edwards Lifesciences position peaked at $1.05M in Q4 2024.
1,204 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on TIG Advisors LLC's 13F filing for Q1 2025, filed 15 May 2025.